GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 63 filers reported holding GAMIDA CELL LTD in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,034 | -83.7% | 1,975 | -69.4% | 0.00% | -100.0% |
| Q2 2023 | $12,449 | +116.9% | 6,450 | -9.0% | 0.00% | +100.0% |
| Q1 2023 | $5,739 | -37.2% | 7,085 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $9,140 | -16.9% | 7,085 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $11,000 | -15.4% | 7,085 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $13,000 | -55.2% | 7,085 | 0.0% | 0.00% | -60.0% |
| Q1 2022 | $29,000 | +61.1% | 7,085 | 0.0% | 0.01% | +66.7% |
| Q4 2021 | $18,000 | +50.0% | 7,085 | +126.0% | 0.00% | +50.0% |
| Q3 2021 | $12,000 | -40.0% | 3,135 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $20,000 | -20.0% | 3,135 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $25,000 | +78.6% | 3,135 | +83.3% | 0.01% | +66.7% |
| Q4 2020 | $14,000 | – | 1,710 | +8450.0% | 0.00% | – |
| Q3 2020 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $9,985,000 | 2.25% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $721,000 | 0.56% |
| Rock Springs Capital Management LP | 2,154,300 | $8,940,000 | 0.22% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,195,000 | 0.20% |
| Platform Technology Partners | 55,625 | $231,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,000,000 | $4,150,000 | 0.10% |
| Guild Investment Management, Inc. | 18,000 | $75,000 | 0.08% |
| FEDERATED HERMES, INC. | 5,128,300 | $21,282,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $1,782,000 | 0.03% |
| 1492 Capital Management LLC | 10,000 | $42,000 | 0.02% |